Immatics (IMTX) Interest & Investment Income (2019 - 2025)
Immatics' (IMTX) quarterly Interest & Investment Income came in at -$15.9 million in Q3 2025, up 20.22% year-on-year from -$13.3 million in Q3 2024, and down 231.73% quarter-over-quarter from $12.1 million in Q2 2025.
Immatics (IMTX) Interest & Investment Income (2019 - 2025) Analysis & Trends
Immatics has disclosed Interest & Investment Income across 7 years of filings, most recently posting -$15.9 million for Q3 2025.
- Interest & Investment Income for Q3 2025 came in at -$15.9 million, up 20.22% year-over-year; the trailing twelve-month figure through Sep 2025 was -$15.9 million (up 20.22% YoY), and the FY2025 annual result was $20.9 million, down 55.53% from the prior year.
- Interest & Investment Income came in at -$15.9 million for Q3 2025 at Immatics, down from $12.1 million in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $16.8 million in Q3 2022 to a low of -$20.0 million in Q3 2024.
- The 5-year median for Interest & Investment Income is -$81938.6 (2021), against an average of $966520.0.
- Across the five-year window, Interest & Investment Income soared 14025.38% in 2022 and sank 35826.69% in 2023, its largest moves.
- Immatics' Interest & Investment Income stood at -$152148.1 in 2021, then jumped by 11109.31% to $16.8 million in 2022, then dropped by 6.33% to $15.7 million in 2023, then slumped by 227.28% to -$20.0 million in 2024, then rose by 20.22% to -$15.9 million in 2025.
- The last three Interest & Investment Income figures came in at -$15.9 million (Q3 2025), $12.1 million (Q2 2025), and -$5.7 million (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 597,319.59 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 305,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -14.79 Mn |
| 10 | Immatics | 14.67 Bn | 14.67 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -15.93 Mn |
| Jun 30, 2025 | 12.09 Mn |
| Mar 31, 2025 | -5.75 Mn |
| Sep 30, 2024 | -19.97 Mn |
| Jun 30, 2024 | -13.63 Mn |
| Mar 31, 2024 | 12.36 Mn |
| Sep 30, 2023 | 15.69 Mn |
| Jun 30, 2023 | 7.35 Mn |
| Mar 31, 2023 | -2.42 Mn |
| Sep 30, 2022 | 16.75 Mn |
| Jun 30, 2022 | 9.36 Mn |
| Mar 31, 2022 | -6,734.03 |
| Dec 31, 2021 | -152,148.14 |
| Sep 30, 2021 | -120,287.31 |
| Jun 30, 2021 | -104,771.62 |
| Mar 31, 2021 | -59,105.57 |
| Dec 31, 2020 | 3.52 Mn |
| Sep 30, 2020 | -1.25 Mn |
| Jun 30, 2020 | -831,602.40 |
| Mar 31, 2020 | -352,156.55 |